Medi Xpert India Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -44.12%
- Profit Growth -30.75%
- Ebitda -202.98%
- Net Worth -27.54%
- Total Assets -44.37%
About Medi Xpert India
Medi Xpert India Limited (MXIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 17 July 2008 and has a history of 16 years and six months. Its registered office is in Delhi, India.
The Corporate was formerly known as Roussel Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Bharatia, Vishnu Halwai, and Husain Baquar serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33110DL2008PLC181020
-
Company No.
181020
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
17 Jul 2008
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Medi Xpert India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Bharatia
|
Director | 17-Jul-2008 | Current |
|
Vishnu Halwai
|
Director | 21-May-2012 | Current |
|
Husain Baquar
|
Director | 05-May-2015 | Current |
Financial Performance of Medi Xpert India.
Medi Xpert India Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.12% decrease. The company also saw a substantial fall in profitability, with a 30.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medi Xpert India?
In 2023, Medi Xpert India had a promoter holding of 68.89% and a public holding of 31.11%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medi Xpert India?
Unlock and access historical data on people associated with Medi Xpert India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medi Xpert India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medi Xpert India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
